The reconstitution process follows the same principles as Retatrutide, with gentle mixing and proper storage in the refrigerator
Cycle length is typically 4 to 8 weeks, with a clinical review at the midpoint to assess response
The brand printed on the label is less informative than the documentation available for the product inside the vial
Why it was included in the FDA ban The FDA cites risk for immunogenicity, peptide-related impurities, and limited safety-related information as reasons for the BPC-157 ban
The injection is repleting vital nutrients and supporting your metabolism
Patients who are pregnant, breastfeeding, managing a chronic medical condition, taking multiple medications, recovering from surgery, or dealing with unexplained pain should speak with a provider before using BPC-157